Vilazodone Hydrochloride Tablet
Product Images NDC 82804-128

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Vilazodone Hydrochloride (NDC 82804-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-128-30 (40mg 30label)

82804-128-30 (40mg 30label)
This is a description of a medication labeled as Vilazodone HCI 40mg tablets. The tablets are blue-colored, ellipse-shaped, and film-coated. Each tablet contains 40mg of vilazodone hydrochloride. The tablets are debossed with "MV" and "16" on one side. The manufacturer is MSN Laboratories Private Limited in Telangana, India. The medication should be stored at 25°C (77°F) and kept out of the reach of children. The medication guide should be dispensed to each patient.*
FDA Label Image

Structural Formula (Structural Formula)

FDA Label Image

Figure 1 (Vii00 0013 02)

Figure 1 (Vii00 0013 02)
This is a list of different medications and their effects on CYP3A5 enzymes. It includes ethanol, ketoconazole as CYP3A5 inhibitors, carbamazepine as a CYP3A5 inducer, and pantoprazole as a proton pump inhibitor. The text also mentions terms like Cmax, Auc, and Fold Change. These drugs play a role in altering the levels of CYP3A5 enzymes in the body, which can impact how other medications are metabolized.*
FDA Label Image

Figure 2 (Vii00 0013 03)

FDA Label Image

Figure 3 (Vii00 0013 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.